Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

275 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Predictive and prognostic markers in neuro-oncology.
van den Bent MJ, Kros JM. van den Bent MJ, et al. Among authors: kros jm. J Neuropathol Exp Neurol. 2007 Dec;66(12):1074-81. doi: 10.1097/nen.0b013e31815c39f1. J Neuropathol Exp Neurol. 2007. PMID: 18090916 Review.
Ultrastructural characterization of transitional cells in oligodendrogliomas.
Kros JM, de Jong AA, van der Kwast TH. Kros JM, et al. J Neuropathol Exp Neurol. 1992 Mar;51(2):186-93. doi: 10.1097/00005072-199203000-00008. J Neuropathol Exp Neurol. 1992. PMID: 1538242
Prognostic relevance of DNA flow cytometry in oligodendroglioma.
Kros JM, van Eden CG, Vissers CJ, Mulder AH, van der Kwast TH. Kros JM, et al. Cancer. 1992 Apr 1;69(7):1791-8. doi: 10.1002/1097-0142(19920401)69:7<1791::aid-cncr2820690722>;2-z. Cancer. 1992. PMID: 1551064
Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families.
Heutink P, Stevens M, Rizzu P, Bakker E, Kros JM, Tibben A, Niermeijer MF, van Duijn CM, Oostra BA, van Swieten JC. Heutink P, et al. Among authors: kros jm. Ann Neurol. 1997 Feb;41(2):150-9. doi: 10.1002/ana.410410205. Ann Neurol. 1997. PMID: 9029063
Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
Rosso SM, van Dekken H, Krishnadath KK, Alers JC, Kros JM. Rosso SM, et al. Among authors: kros jm. J Neuropathol Exp Neurol. 1997 Oct;56(10):1125-31. doi: 10.1097/00005072-199710000-00006. J Neuropathol Exp Neurol. 1997. PMID: 9329456
Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.
van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. van Veelen ML, et al. Among authors: kros jm. J Neurol Neurosurg Psychiatry. 1998 May;64(5):581-7. doi: 10.1136/jnnp.64.5.581. J Neurol Neurosurg Psychiatry. 1998. PMID: 9598670 Free PMC article.
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.
van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, van Groeningen CJ, Krouwer HG, Taphoorn MJ, Zonnenberg BA, Tijssen CC, Twijnstra A, Punt CJ, Boogerd W. van den Bent MJ, et al. Among authors: kros jm. Neurology. 1998 Oct;51(4):1140-5. doi: 10.1212/wnl.51.4.1140. Neurology. 1998. PMID: 9781544
Cytogenetic analysis of gemistocytic cells in gliomas.
Kros JM, Waarsenburg N, Hayes DP, Hop WC, van Dekken H. Kros JM, et al. J Neuropathol Exp Neurol. 2000 Aug;59(8):679-86. doi: 10.1093/jnen/59.8.679. J Neuropathol Exp Neurol. 2000. PMID: 10952058
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading.
Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S, Graeber MB, Bauserman S, Buckner JC, Burton J, Riepe R, Tazelaar HD, Nascimento AG, Crotty T, Keeney GL, Pernicone P, Altermatt H. Giannini C, et al. Among authors: kros jm. J Neuropathol Exp Neurol. 2001 Mar;60(3):248-62. doi: 10.1093/jnen/60.3.248. J Neuropathol Exp Neurol. 2001. PMID: 11245209
Temozolomide chemotherapy in recurrent oligodendroglioma.
van den Bent MJ, Keime-Guibert F, Brandes AA, Taphoorn MJ, Kros JM, Eskens FA, Carpentier AF. van den Bent MJ, et al. Among authors: kros jm. Neurology. 2001 Jul 24;57(2):340-2. doi: 10.1212/wnl.57.2.340. Neurology. 2001. PMID: 11468326
275 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page